Your browser doesn't support javascript.
loading
Viral inactivation of intramuscular immune serum globulins.
Alonso, W R; Trukawinski, S; Savage, M; Tenold, R A; Hammond, D J.
Afiliación
  • Alonso WR; Technology Department, Bayer Corporation, Clayton, NC 27520, USA. bill.alonso.b@bayer.com
Biologicals ; 28(1): 5-15, 2000 Mar.
Article en En | MEDLINE | ID: mdl-10799050
A new process for the production of intramuscular immunoglobulin products is described which includes viral inactivation through solvent-detergent treatment. Removal of solvent-detergent was accomplished by precipitation, filtration and diafiltration. Process-scale preparations had appropriate antibody potency levels, and improved IgG integrity relative to traditional IGIM products. Moreover, acceptable results were obtained in all in vitro and in vivo pre-clinical toxicology testing, as well as clinical evaluation. Scaled-down experiments demonstrated that the new process provides effective viral inactivation. Taken together, these results indicate that the new products should have the same efficacy of the previous IGIM products albeit with safety and processing improvements.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Organofosfatos / Inmunoglobulinas / Contaminación de Medicamentos / VIH-1 / Colato de Sodio Límite: Humans Idioma: En Revista: Biologicals Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2000 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Organofosfatos / Inmunoglobulinas / Contaminación de Medicamentos / VIH-1 / Colato de Sodio Límite: Humans Idioma: En Revista: Biologicals Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2000 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido